300 related articles for article (PubMed ID: 23789952)
1. Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.
Lai Y; Hsiao P
Curr Pharm Des; 2014; 20(10):1577-94. PubMed ID: 23789952
[TBL] [Abstract][Full Text] [Related]
2. Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research.
Tang H; Shen DR; Han YH; Kong Y; Balimane P; Marino A; Gao M; Wu S; Xie D; Soars MG; O'Connell JC; Rodrigues AD; Zhang L; Cvijic ME
J Biomol Screen; 2013 Oct; 18(9):1072-83. PubMed ID: 24062352
[TBL] [Abstract][Full Text] [Related]
3. Emerging transporters of clinical importance: an update from the International Transporter Consortium.
Hillgren KM; Keppler D; Zur AA; Giacomini KM; Stieger B; Cass CE; Zhang L;
Clin Pharmacol Ther; 2013 Jul; 94(1):52-63. PubMed ID: 23588305
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drug transporter interactions in drug discovery and development.
Lai Y; Sampson KE; Stevens JC
Comb Chem High Throughput Screen; 2010 Feb; 13(2):112-34. PubMed ID: 20053160
[TBL] [Abstract][Full Text] [Related]
5. Highlights from the International Transporter Consortium second workshop.
Zamek-Gliszczynski MJ; Hoffmaster KA; Tweedie DJ; Giacomini KM; Hillgren KM
Clin Pharmacol Ther; 2012 Nov; 92(5):553-6. PubMed ID: 23085880
[TBL] [Abstract][Full Text] [Related]
6. Role of Hepatic Drug Transporters in Drug Development.
Liu H; Sahi J
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
8. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
Langer O
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172
[TBL] [Abstract][Full Text] [Related]
9. SLC transporters as therapeutic targets: emerging opportunities.
Lin L; Yee SW; Kim RB; Giacomini KM
Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
[TBL] [Abstract][Full Text] [Related]
10. Effects of Drug Transporters on Pharmacological Responses and Safety.
Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
[TBL] [Abstract][Full Text] [Related]
11. Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium.
Tweedie D; Polli JW; Berglund EG; Huang SM; Zhang L; Poirier A; Chu X; Feng B;
Clin Pharmacol Ther; 2013 Jul; 94(1):113-25. PubMed ID: 23588318
[TBL] [Abstract][Full Text] [Related]
12. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
Chu X; Chan GH; Evers R
J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420
[TBL] [Abstract][Full Text] [Related]
13. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
Varma MV; El-Kattan AF
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.
Li R; Barton HA; Varma MV
Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496
[TBL] [Abstract][Full Text] [Related]
15. Transporter assays as useful in vitro tools in drug discovery and development.
Volpe DA
Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
[TBL] [Abstract][Full Text] [Related]
16. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.
Hau RK; Wright SH; Cherrington NJ
Clin Pharmacol Ther; 2023 Oct; 114(4):780-794. PubMed ID: 37404197
[TBL] [Abstract][Full Text] [Related]
17. In vitro methods to support transporter evaluation in drug discovery and development.
Brouwer KL; Keppler D; Hoffmaster KA; Bow DA; Cheng Y; Lai Y; Palm JE; Stieger B; Evers R;
Clin Pharmacol Ther; 2013 Jul; 94(1):95-112. PubMed ID: 23588315
[TBL] [Abstract][Full Text] [Related]
18. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.
Zamek-Gliszczynski MJ; Taub ME; Chothe PP; Chu X; Giacomini KM; Kim RB; Ray AS; Stocker SL; Unadkat JD; Wittwer MB; Xia C; Yee SW; Zhang L; Zhang Y;
Clin Pharmacol Ther; 2018 Nov; 104(5):890-899. PubMed ID: 30091177
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of transporters in drug development: Current status and contemporary issues.
Lee SC; Arya V; Yang X; Volpe DA; Zhang L
Adv Drug Deliv Rev; 2017 Jul; 116():100-118. PubMed ID: 28760687
[TBL] [Abstract][Full Text] [Related]
20. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
